Sugi Predict

Sugi Predict / Compounds / SCHEMBL1779495

SCHEMBL1779495

SCHEMBL1779495

CS(=O)(=O)OCCc1cnc2ccccn12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GGPS1 O95749 1/20 0.45
▸ FDPS P14324 1/20 0.45
▸ GPR84 Q9NQS5 1/20 0.40
▸ HDAC1 Q13547 1/20 0.39
▸ DRD4 P21917 1/20 0.38
▸ DRD3 P35462 1/20 0.38
▸ NAMPT P43490 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.37
▸ ADORA3 P0DMS8 1/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ KDM4E B2RXH2 3/20 0.36
▸ LMNA P02545 1/20 0.36
▸ RAB9A P51151 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ FLT3 P36888 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ PIK3CA P42336 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ GLA P06280 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31295234 0.78 PDE10A (0.42) DRD4ALDH1A1KDM4ERAB9AMAPT
SCHEMBL12801878 0.76 GGPS1 (0.50) GGPS1FDPSGPR84HDAC1DRD4
SCHEMBL8245596 0.75 TLR7 (0.51) GGPS1FDPSGPR84HDAC1DRD4
SCHEMBL7841739 0.73 CDK8 (0.36) ALDH1A1ADORA3KDM4ELMNA
SCHEMBL10666089 0.72 GGPS1 (0.50) GGPS1FDPSGPR84HDAC1DRD4
SCHEMBL7222910 0.72 GGPS1 (0.50) GGPS1FDPSGPR84HDAC1DRD4
SCHEMBL3924701 0.72 GGPS1 (0.54) GGPS1FDPSGPR84HDAC1DRD4
SCHEMBL3796430 0.72 GGPS1 (0.50) GGPS1FDPSGPR84HDAC1DRD4
SCHEMBL7842368 0.72 KDM4E (0.39) ALDH1A1ADORA3KDM4ELMNA
SCHEMBL8360107 0.72 GGPS1 (0.53) GGPS1FDPSGPR84HDAC1DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025021120-A1 5-HT2A RECEPTOR AGONIST, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海翊石医药科技有限公司 2025-01-30 — — WO disclosed
EP-2260020-B1 HYDROXAMATE-BASED INHIBITORS OF DEACETYLASES B NOVARTIS AG (CH) 2014-07-23 — — EP disclosed
EP-2628726-A1 Hydroxamate-based inhibitors of deacetylases b Novartis AG (CH) 2013-08-21 — — EP disclosed
US-8349883-B2 Hydroxamate-based inhibitors of deacetylases B NOVARTIS AG (CH) 2013-01-08 — — US disclosed
US-20110183964-A1 HYDROXAMATE-BASED INHIBITORS OF DEACETYLASES B NOVARTIS AG (CH) 2011-07-28 — — US disclosed
US-7943652-B2 Hydroxamate-based inhibitors of deacetylases B NOVARTIS AG (CH) 2011-05-17 — — US disclosed
EP-2260020-A1 HYDROXAMATE-BASED INHIBITORS OF DEACETYLASES B Novartis AG (CH) 2010-12-15 — — EP disclosed
US-20090247547-A1 HYDROXAMATE-BASED INHIBITORS OF DEACETYLASES B NOVARTIS AG 2009-10-01 — — US disclosed
WO-2009118305-A1 HYDROXAMATE-BASED INHIBITORS OF DEACETYLASES B NOVARTIS AG (CH) 2009-10-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247547-A1 HYDROXAMATE-BASED INHIBITORS OF DEACETYLASES B HDAC1, HDAC11, HDAC3 GGPS1 2815/4885FDPS 1381/4885GPR84 2498/4885
US-20110183964-A1 HYDROXAMATE-BASED INHIBITORS OF DEACETYLASES B HDAC1, HDAC11, HDAC3 GGPS1 2815/4885FDPS 1381/4885GPR84 2498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.